SHAREHOLDER NOMINATION AND VOTING AGREEMENTShareholder Agreement • April 28th, 2025 • Becaril S.A. • Pharmaceutical preparations • New York
WHEREAS, on November 29, 2024, the Company (as defined below) initiated a private offering of Ordinary Shares to accredited investors, as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in a transaction or series of transactions, exempt from registration under the Securities Act, which is being effectuated as of the Effective Date (the “Company Equity Offering”);
SHAREHOLDER NOMINATION AND VOTING AGREEMENTShareholder Agreement • April 25th, 2025 • Chemo Project, S.A. • Pharmaceutical preparations • New York
WHEREAS, on November 29, 2024, the Company (as defined below) initiated a private offering of Ordinary Shares to accredited investors, as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in a transaction or series of transactions, exempt from registration under the Securities Act, which is being effectuated as of the Effective Date (the “Company Equity Offering”);